| Commentary |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Ten-Year Relative Survival and Causes of Death in Elderly Patients Treated With R-CHOP or CHOP in the GELA LNH-985 Trial
02 February 2012
Advances in lymphoma therapy have resulted in improved cure rates and an increasing number of long-term survivors. The addition of rituximab (R) to the standard treatment regimen composed of cyclophos...
|
Nicolas Mounier,
Natacha Heutte,
Catherine Thieblemont,
Josette Briere,
Philippe Gaulard,
Pierre Feugier,
Hervé Ghesquieres,
Eric Van Den Neste,
Daniela Robu,
Herve Tilly,
Reda Bouabdallah,
Violaine Safar,
Bertrand Coiffier,
Groupe d'Etude des Lymphomes de l'Adulte (GELA)
et al.
|
151-154
|
|
| Reviews |
| |
Article Title |
Author(s) |
Pages |
|
|
|
TRAF6 Activation in Multiple Myeloma: A Potential Therapeutic Target
23 March 2012
Abstract: Multiple myeloma (MM) is an incurable B-lymphocyte malignancy. New therapeutic options have become available during the past several years; however nearly all patients acquire resistance to ...
|
Hong Liu,
Samantha Tamashiro,
Stavroula Baritaki,
Manuel Penichet,
Youhua Yu,
Haiming Chen,
James Berenson,
Benjamin Bonavida
et al.
|
155-163
|
|
|
|
Spectrum of Neurologic Complications in Chronic Lymphocytic Leukemia
23 December 2011
Abstract: Neurologic disease is believed to be an unusual complication during the course of chronic lymphocytic leukemia. Nevertheless, it has already been proven in autopsy series that the incidence ...
|
Rodrigo Lopes da Silva
|
164-179
|
|
| Original Studies |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Pilot Study of Denileukin Diftitox Alternate Dosing Regimen in Patients With Cutaneous Peripheral T-Cell Lymphomas
23 April 2012
Micro-Abstract: Better treatment and survival outcomes are needed for the rare primary cutaneous peripheral T-cell lymphomas. Five (62.5%) of 8 patients with peripheral T-cell lymphomas enrolled in a ...
|
Rakhshandra Talpur,
Madeleine Duvic
|
180-185
|
|
|
|
Phase II Trial of Syncopated Thalidomide, Lenalidomide, and Weekly Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
01 March 2012
Micro-Abstract: Thalidomide and lenalidomide, in combination with dexamethasone, provide response rates ranging from 63%-79% after 4 cycles of therapy. Because of toxicities such as neuropathy and mye...
|
Madiha Tufail,
David S. Siegel,
Laura McBride,
Elizabeth Bilotti,
Erica Bello,
Palka Anand,
Karly Olivo,
Urszula Bendarz,
Ann McNeill,
David H. Vesole
et al.
|
186-190
|
|
|
|
Successful Treatment of Patients With Multiple Myeloma and Impaired Renal Function With Lenalidomide: Results of 4 German Centers
20 February 2012
Micro-Abstract: Retrospective multicenter analysis of 26 patients with multiple myeloma to assess the efficacy and toxicity of relapse treatment with lenalidomide/dexamethasone in renal-function impai...
|
Katharina Oehrlein,
Christian Langer,
Isrid Sturm,
Wolfram Pönisch,
Corinna Hahn-Ast,
Sigrid Kuhn,
Katja C. Weisel
et al.
|
191-196
|
|
|
|
Phase I-II Study of Bendamustine in Patients With Acute Leukemia and High Risk Myelodysplastic Syndrome
Micro-Abstract: A phase I-II study of bendamustine fractionated twice daily schedule for 4 days identified 75 mg/m2 intravenously (IV) twice daily for 4 days as a phase II study schedule.Abstract: Bac...
|
Christelle Chacar,
Elias Jabbour,
Farhad Ravandi,
Gautam Borthakur,
Tapan Kadia,
Zeev Estrov,
Mary Beth Rios,
Jorge Cortes,
Hagop Kantarjian
et al.
|
197-200
|
|
|
|
IGHV3-21 Gene Frequency in a Swedish Cohort of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
05 April 2012
Micro-Abstract: The IGHV3-21 gene has been shown to be overrepresented in Scandinavian patients with chronic lymphocytic leukemia (CLL). By investigating a population-based cohort of 337 Swedish patie...
|
Nicola Cahill,
Lesley-Ann Sutton,
Mattias Jansson,
Fiona Murray,
Larry Mansouri,
Rebeqa Gunnarsson,
Fergus Ryan,
Karin E. Smedby,
Christian Geisler,
Gunnar Juliusson,
Richard Rosenquist
et al.
|
201-206
|
|
|
|
Epigenetic Therapy With Hydralazine and Magnesium Valproate Reverses Imatinib Resistance in Patients With Chronic Myeloid Leukemia
15 March 2012
Micro-Abstract: The epigenetic drugs hydralazine and valproate were administered in a compassionate manner to 8 patients with chronic myeloid leukemia (CML) refractory to imatinib. Two patients had a ...
|
Eduardo Cervera,
Myrna Candelaria,
Omar López-Navarro,
Juan Labardini,
Aurora Gonzalez-Fierro,
Lucia Taja-Chayeb,
Jorge Cortes,
Daniela Gordillo-Bastidas,
Alfonso Dueñas-González
et al.
|
207-212
|
|
| Case Reports |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Non-Hodgkin Lymphoma in a Child With Neuroblastoma Preceding Autologous Stem Cell Transplant
|
Julie Blatt,
Michael LaQuaglia,
John P. Hunt,
David E. Morris,
Kimberly A. Kasow
et al.
|
213-215
|
|
|
|
Is the Angioimmunoblastic T-Cell Lymphoma Beneficial to Avoid CD4+ Lymphopenia and Other AIDS Manifestations in Patients Infected With Human Immunodeficiency Virus?
05 March 2012
|
Julio A. Diaz-Perez,
Gabriel A. Hurtado-Gomez,
Juan S. Barajas-Gamboa
|
216-219
|
|
|
|
Syndrome of Inappropriate Antidiuretic Hormone Secretion due to Marginal Zone Lymphoma: Responding to Rituximab
|
Bruno Bockorny,
Constantin A. Dasanu
|
220-222
|
|
| Frontmatter |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Editorial Board/Masthead
|
|
A5
|
|
|
|
Table of Contents
|
|
A11-A12
|
|
